Dittmann, R. (2013). Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: A head-to-head, randomized, double-blind, phase IIIb study. CNS drugs, 27(12), .
Chicago Style (17th ed.) CitationDittmann, Ralf. "Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-deficit/hyperactivity Disorder: A Head-to-head, Randomized, Double-blind, Phase IIIb Study." CNS Drugs 27, no. 12 (2013).
MLA (9th ed.) CitationDittmann, Ralf. "Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-deficit/hyperactivity Disorder: A Head-to-head, Randomized, Double-blind, Phase IIIb Study." CNS Drugs, vol. 27, no. 12, 2013.
Warning: These citations may not always be 100% accurate.